(Q33755778)

English

Comparison of QTc data analysis methods recommended by the ICH E14 guidance and exposure-response analysis: case study of a thorough QT study of asenapine

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Comparison of QTc data analysis methods recommended by the ICH E14 guidance and exposure-response analysis: case study of a thorough QT study of asenapine (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

0 references

author name string

S Chapel

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

M M Hutmacher

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

H Bockbrader

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

R de Greef

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

R L Lalonde

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

24 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

89

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

75-80

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Clinical evaluation of QT/QTc prolongation and proarrhythmic potential for nonantiarrhythmic drugs: the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use E14 guideline.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.220

21 January 2018

Exposure-response analysis in patients with schizophrenia to assess the effect of asenapine on QTc prolongation

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.220

21 January 2018

Performance characteristics for some typical QT study designs under the ICH E-14 guidance.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.220

21 January 2018

Concentration-QT relationships play a key role in the evaluation of proarrhythmic risk during regulatory review.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.220

21 January 2018

Response to letter to the editor: Statistical issues of QT prolongation assessment based on linear concentration modeling by Yi Tsong et al.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.220

21 January 2018

A perspective on the use of concentration-QT modeling in drug development

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.220

7 January 2021

based on heuristic

inferred from DOI database lookup

Modeling and Interpreting QTc Prolongation in Clinical Pharmacology Studies

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.220

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/CLPT.2010.220

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33755778&oldid=1534204163"